6 research outputs found

    Kognitiv-psychoedukative Gruppenintervention bei stationären Patienten mit depressiven Erkrankungen – Ergebnisse einer prospektiven Pilotstudie

    Get PDF
    Background: Psychoeducational interventions that provide disorder-related information in a goal-oriented and structured manner have been integrated in psychiatric and psychotherapeutic approaches. The present cognitive psychoeducational group programme for inpatients with affective disorders is based on a multidimensional functional illness concept which covers aspects of vulnerability, stressors and coping strategies. It covers information about the disorder and its treatment options, building up rewarding activities, cognitive restructuring and relapse prevention. Materials und Methods: This programme was developed and modified at the University of Munich, Department of Psychiatry (LMU). A feasibility study was set up in a follow-up single group design and analyses of variance (ANOVAs) were performed. A total of 231 patients participated in 46 groups. Results: 125 patients evaluated the effectiveness of the programme and its treatment strategies. The group programme was widely accepted among patients that were pharmacologically and psychotherapeutically treated: more than three quarters of the patients rated its contents to be informative, helpful and applicable to everyday living. Conclusions: Inpatients with affective disorders may already benefit from a structured group programme if it takes into account their cognitive and motivational deficits. The group leaders' didactic and psychotherapeutic strategies as well as the patients' exchanging ideas with each other play a central role. In the course of further investigations the programme was differentiated for patients with major depression or bipolar disorders

    A perspective on Hypericum perforatum Genetic transformation

    Get PDF
    Hypericum perforatum (St John's wort) is a reservoir of diverse classes of biologically active and high value secondary metabolites, which captured the interest of both researchers and the pharmaceutical industry alike. Several studies and clinical trials have shown that H. perforatum extracts possess an astounding array of pharmacological properties. These properties include antidepressant, anti-inflammatory, antiviral, anti-cancer, and antibacterial activities; and are largely attributed to the naphtodianthrones and xanthones found in the genus. Hence, improving their production via genetic manipulation is an important strategy. In spite of the presence of contemporary genome editing tools, genetic improvement of this genus remains challenging without robust transformation methods in place. In the recent past, we found that H. perforatum remains recalcitrant to Agrobacterium tumefaciens mediated transformation partly due to the induction of plant defense responses coming into play. However, H. perforatum transformation is possible via a non-biological method, biolistic bombardment. Some research groups have observed the induction of hairy roots in H. perforatum after Agrobacterium rhizogenes co-cultivation. In this review, we aim at updating the available methods for regeneration and transformation of H. perforatum. In addition, we also propose a brief perspective on certain novel strategies to improve transformation efficiency in order to meet the demands of the pharmaceutical industry via metabolic engineering.GF and PS are financed from the BIOTALENT project (GA621321) funded by the European Union Seventh Framework Programme (FP7) ERA Chairs Pilot Call and co-financed by funds allocated for education through project no W26/7.PR/2015 [GA 3413/7.PR/2015/2] for the years 2015-2019. This work was partially supported by Fundacao para a Ciencia e a Tecnologia (FCT) project (PTDC/AGR-GPL/119211/2010). WEE acknowledges the financial support provided by the FCT (SFRH/BD/52561/2014), under the Doctoral Programme "Agricultural Production Chains-from fork to farm" (PD/00122/2012).info:eu-repo/semantics/publishedVersio

    Chemistry and Biology of the Polycyclic Polyprenylated Acylphloroglucinol Hyperforin

    No full text

    Drug treatment of depression in the 2000s: an overview of achievements in the last 10 years and future possibilities

    No full text

    The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders

    No full text
    corecore